Atlas Trials

Transfusion of Pathogen Reduced Cryoprecipitated Fibrinogen to Expedite Product Availability in Perioperative Bleeding

Clinical trial NCT05711524 · COMPLETED

Trial details

NCT number
NCT05711524
Sponsor
Weill Medical College of Cornell University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
HypofibrinogenemiaBleeding
Start date
2023-04-01
Primary completion
2024-10-23
Enrollment
208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.